Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · abrdn Global Infrastructure Income Fund (ASGI)

abrdn Global Infrastructure Income Fund opens rights offering of new shares

Neutral Impact 3 of 5 financing Written later

On September 21, 2026, abrdn Global Infrastructure Income Fund commenced a rights offering to holders of record on that date, under a dealer manager agreement with UBS Securities LLC. The offer covers up to 10,545,755 new common shares, and the rights expire on October 15, 2026 unless extended, so existing shareholders must decide whether to subscribe before then.

Key points

  • Each common share held at the close of business on September 21, 2026 receives one right; three rights are needed to buy one new common share.
  • The offer covers up to 10,545,755 common shares of beneficial interest, par value $0.001 per share.
  • Rights expire at 5:00 p.m. Eastern time on October 15, 2026 unless extended; Equiniti Trust Company, LLC is the subscription agent and EQ Fund Solutions, LLC the information agent.

The filing

Companyabrdn Global Infrastructure Income Fund (ASGI)
Form8-K, current report
Filed with the SECSep 21, 2026, 9:43 PM ET
Accession number0001104659-26-109410

Items reported: 1.01 Material Definitive Agreement8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.